Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
26
IART Quote, Financials, Valuation and Earnings
Last price:
$13.58
Seasonality move
:
2.23%
Day range:
$13.32 - $13.75
52-week range:
$10.87 - $27.13
Dividend yield:
0%
P/E ratio:
70.14x
P/S ratio:
0.63x
P/B ratio:
1.01x
Volume:
820.2K
Avg. volume:
1.2M
1-year change:
-47.65%
Market cap:
$1.1B
Revenue:
$1.6B
EPS (TTM):
-$6.46
Analysts' Opinion
-
Consensus RatingIntegra LifeSciences Holdings Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 5 Hold ratings, and 2 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $15.50, Integra LifeSciences Holdings Corp. has an estimated upside of 14.9% from its current price of $13.57.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $10.00 representing 100% downside risk from its current price of $13.57.
Fair Value
-
According to the consensus of 9 analysts, Integra LifeSciences Holdings Corp. has 14.9% upside to fair value with a price target of $15.50 per share.
IART vs. S&P 500
-
Over the past 5 trading days, Integra LifeSciences Holdings Corp. has overperformed the S&P 500 by 1.8% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Integra LifeSciences Holdings Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Integra LifeSciences Holdings Corp. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Integra LifeSciences Holdings Corp. reported revenues of $402.1M.
Earnings Growth
-
Integra LifeSciences Holdings Corp. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Integra LifeSciences Holdings Corp. reported earnings per share of -$0.07.
Enterprise value:
2.8B
EV / Invested capital:
0.92x
Price / LTM sales:
0.63x
EV / EBIT:
17.59x
EV / Revenue:
1.70x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-192.77x
Price / Operating cash flow:
10.60x
Enterprise value / EBITDA:
9.01x
Gross Profit (TTM):
$915.2M
Return On Assets:
-12.72%
Net Income Margin (TTM):
-30.15%
Return On Equity:
-37.15%
Return On Invested Capital:
-14.85%
Operating Margin:
6.43%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.5B | $1.6B | $1.6B | $380.8M | $402.1M | |
| Gross Profit | $933.4M | $907.6M | $915.2M | $214.4M | $226.1M | |
| Operating Income | $230.7M | $145.3M | $158.6M | $14M | $25.9M | |
| EBITDA | $352.7M | $279.2M | $309.4M | $50M | $64.3M | |
| Diluted EPS | $1.22 | -$0.09 | -$6.46 | -$0.14 | -$0.07 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.1B | $1.2B | $1B | $1.1B | $1.1B | |
| Total Assets | $3.8B | $3.8B | $3.7B | $4.1B | $3.6B | |
| Current Liabilities | $332.9M | $304.5M | $355.7M | $912.6M | $364.1M | |
| Total Liabilities | $2.1B | $2.1B | $2.2B | $2.5B | $2.6B | |
| Total Equity | $1.6B | $1.7B | $1.6B | $1.5B | $1B | |
| Total Debt | $1.7B | $1.7B | $1.7B | $2B | $2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $166.5M | $137.4M | $89.3M | $22.5M | $40.9M | |
| Cash From Investing | -$91.8M | -$443.8M | -$77.4M | -$10.4M | -$15.6M | |
| Cash From Financing | -$320.7M | $238.1M | -$3.2M | -$19.9M | -$10.2M | |
| Free Cash Flow | $109.8M | $38M | -$14.5M | -$7.2M | $25.8M | |
IART
Sector
Market Cap
$1.1B
$28.4M
Price % of 52-Week High
49.72%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
0.22%
-1.32%
1-Year Price Total Return
-45.23%
-22.19%
Beta (5-Year)
1.064
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$13.16
200-day SMA
Sell
Level
$15.12
Bollinger Bands (100)
Sell
Level
12.25 - 15.05
Chaikin Money Flow
Buy
Level
88.3M
20-day SMA
Buy
Level
$12.31
Relative Strength Index (RSI14)
Buy
Level
58.41
ADX Line
Buy
Level
17.63
Williams %R
Sell
Level
-5.8394
50-day SMA
Buy
Level
$13.43
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Sell
Level
-20
On Balance Volume
Neutral
Level
82.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.343)
Sell
CA Score
(Annual)
Level (-0.549)
Buy
Beneish M-Score
(Annual)
Level (-2.609)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-4.8797)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Stock Forecast FAQ
In the current month, IART has received 2 Buy ratings 5 Hold ratings, and 2 Sell ratings. The IART average analyst price target in the past 3 months is $15.50.
-
Where Will Integra LifeSciences Holdings Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Integra LifeSciences Holdings Corp. share price will rise to $15.50 per share over the next 12 months.
-
What Do Analysts Say About Integra LifeSciences Holdings Corp.?
Analysts are divided on their view about Integra LifeSciences Holdings Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Integra LifeSciences Holdings Corp. is a Sell and believe this share price will drop from its current level to $10.00.
-
What Is Integra LifeSciences Holdings Corp.'s Price Target?
The price target for Integra LifeSciences Holdings Corp. over the next 1-year time period is forecast to be $15.50 according to 9 Wall Street analysts, 2 of them rate the stock a Buy, 2 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is IART A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Integra LifeSciences Holdings Corp. is a Hold. 5 of 9 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of IART?
You can purchase shares of Integra LifeSciences Holdings Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Integra LifeSciences Holdings Corp. shares.
-
What Is The Integra LifeSciences Holdings Corp. Share Price Today?
Integra LifeSciences Holdings Corp. was last trading at $13.58 per share. This represents the most recent stock quote for Integra LifeSciences Holdings Corp.. Yesterday, Integra LifeSciences Holdings Corp. closed at $13.57 per share.
-
How To Buy Integra LifeSciences Holdings Corp. Stock Online?
In order to purchase Integra LifeSciences Holdings Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get IART Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IART
Sector
P/E ratio
70.14x
23.66x
PEG ratio
0.00x
-0.01x
P/B ratio
1.01x
1.84x
Price / LTM sales
0.63x
1.60x
Growth Metrics
IART
Sector
Revenue growth
5.57%
4.85%
Earnings growth
49.68%
11.15%
Revenue (5-year growth)
1.2%
6.45%
Earnings forecast
$0.43
-$0.20
Profitability
IART
Sector
Profitability FY 2024
$898.8M
$3.6M
Return on invested capital
-14.85%
-30.98%
Return on assets
-12.72%
-27.62%
Return on equity
-37.15%
-36.69%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
24
Estimated Next Earnings Date
Jan
29
Balance Sheet
IART
Sector
Total cash
$267.9M
$27.2M
Short term investments
$27.2M
$25.7M
Total assets
$4B
$79.9M
Long term debt
$2B
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
38
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
